Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
13-week dose-response trial of AVE0010 in metformin-treated adults with type 2 diabetes mellitus
2006-002847-96Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Apr 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lixisenatide in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Sanofi. Primary endpoint: Haemoglobin A1c. Started Apr 2007; status: terminated.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-002847-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002847-96.